Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term multidrug-resistance. Found 17 abstracts

Huo HR, Magro PG, Pietsch EC, Patel BB, Scotto KW. Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance. Cancer Research. 2010 Nov;70(21):8726-35.   PMCID: *
van Vlerken LE, Duan ZF, Little SR, Seiden MV, Amiji MM. Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems. Aaps Journal. 2010 Jun;12(2):171-80.   PMCID: PMC2844507 [Available on 2011/2/9]
Liu H, Cheng D, Weichel AK, Osipo C, Wing LK, Chen B, Louis TE, Jordan VC. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells. INTERNATIONAL JOURNAL OF ONCOLOGY. 2006 Nov;29(5):1237-46.
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescut DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 Jul;103(30):11154-9.
Johnson RA, Shepard EM, Scotto KW. Differential regulation of MDR1 transcription by the p53 family members - Role of the DNA binding domain. Journal of Biological Chemistry. 2005 Apr 08;280(14):13213-9.
Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. British Journal of Cancer. 2005 Dec 12;93(12):1356-63.
Boonstra R, Timmer-Bosscha H, van Echten-Arends J, van der Kolk DM, van den Berg A, de Jong B, Tew KD, Poppema S, de Vries EG. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation. British Journal of Cancer. 2004 Jun;90(12):2411-7.
Fracasso PM, Goldstein LJ, de Alwis DP, Rader JS, Arquette MA, Goodner SA, Wright LP, Fears CL, Gazak RJ, Andre VA, Burgess MF, Slapak CA, Schellens JH. Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies. Clinical Cancer Research. 2004 Nov;10(21):7220-8.
Szakacs G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo YP, Kruh GD, Reimers M, Weinstein JN, Gottesman MM. Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells. Cancer cell. 2004 Aug;6(2):129-37.
Dexter DW, Reddy RK, Geles KG, Bansal S, Myint MA, Rogakto A, Leighton JC, Goldstein LJ. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clinical Cancer Research. 1998 Jun;4(6):1533-42.
Shen HX, Schultz M, Kruh GD, Tew KD. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochimica Et Biophysica Acta-General Subjects. 1998 Jul 23;1381(2):131-8.
Paul S, Breuninger LM, Kruh GD. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells. Biochemistry. 1996 Nov 05;35(44):14003-11.
Smith CD, Zhang XQ. Mechanism of action of cryptophycin - Interaction with the Vinca alkaloid domain of tubulin. Journal of Biological Chemistry. 1996 Mar 15;271(11):6192-8.
Zhang XQ, Smith CD. Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance. Molecular Pharmacology. 1996 Feb;49(2):288-94.
Smith CD, Zilfou JT. Circumvention of P-Glycoprotein-Mediated Multiple-Drug Resistance by Phosphorylation Modulators Is Independent of Protein-Kinases. Journal of Biological Chemistry. 1995 Nov 24;270(47):28145-52.
Zilfou JT, Smith CD. Differential Interactions of Cytochalasins with P-Glycoprotein. Oncology Research. 1995 Jan;7(9):435-43.
Smith CD, Prinsep MR, Caplan FR, Moore RE, Patterson GM. Reversal of Multiple-Drug Resistance by Tolyporphin, a Novel Cyanobacterial Natural Product. Oncology Research. 1994 Jan;6(4-5):211-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term multidrug-resistance

multidrug-resistance expression p-glycoprotein cancer gene transporter drug-resistance binding drug resistance tumor-cells lines analogs resistance-associated protein p53 vinblastine growth p-glycoprotein expression ovarian-cancer structural features cells cell-lines paclitaxel accumulation mdr breast-cancer estramustine assay wild-type p53 combination therapy fulvestrant-resistance in-vivo breast cancer-cells breast cancer-resistance protein 1 Ku 2 gene-expression gene- modulator DNA-PK hl60 cells tolyporphin molecular pharmacology zd1839 iressa feedback loop ph-sensitive system cyto-toxicity human ovarian-cancer microtubule assembly invitro intracellular ceramide modulation antimitotic agent apoptosis sdz psc 833 drug efflux capacity reversal hl-60 cells poly(beta-amino ester) nanoparticles temporal-controlled polymeric nanoparticle delivery tubulin colon cancer solid tumors staurosporine vincristine taxol database lines resistant messenger-rna hypoxia Oncology p73 family potent inhibitor kb cells p63 phorbol esters cell-cycle liver canalicular membrane patterns adriamycin chemosensitizers p63 isoforms polymerization glycoprotein polymorphism h3k4 methylation ku-autoantigen leukemia-cells targeted delivery cell lung-cancer protein family nf-y breast cancer resistance transporter abcg2 angiogenesis therapy cell-proliferation in-vitro cytochalasins Multidisciplinary Sciences transport postmenopausal women modulation selective inhibitor doxorubicin chromatin survival 4-dichlorobenzyl thiocyanate glucosylceramide EGFR membrane clinical-relevance mechanism carcinoma v(d)j recombination strand-break repair protein receptor antagonist multidrug chemosensitivity inhibition cassette pharmacology dynamic instability adriamycin resistance screen tumor-cell myeloid-leukemia drug disposition cancer stem cells agents pure antiestrogen trihydrochloride ly335979 hydrophobic drugs phosphorylation statistics tyrosine kinase inhibitor breast cancer resistant protein cisplatin overexpression trial cyclosporine acute lymphoblastic-leukemia dolastatin-10 drugs spontaneous tumors acute human-breast-cancer heterogeneity catalytic subunit colchicine-binding-site
Last updated on Saturday, August 15, 2020